Drugs / Live Combined B. Subtilis and E. Faecium Enteric-coated Capsules
Live Combined B. Subtilis and E. Faecium Enteric-coated Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07065942 | Jul 2023 → Jul 2026 overdue | constipation disorder, diabetes mellitus | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Combined B. Subtilis and E. Faecium Enteric-coated Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07065942 ↗ |
| Route | Oral | “Oral, 2 tablets (500 mg per tablet) three times daily (TID).” NCT07065942 ↗ |